FT-4101

· Forma Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FT-4101, covering 2024-11-21 to 2024-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis [Phase 1, Phase 2]